PharmTech AI Pulse Check episode 2 covers AI data governance, API-gated journals, watermarking limits, and why attribution beats detection in GxP.
News|Articles|June 18, 2015
MFG Tray Recognizes Distributor
Author(s)Pharmaceutical Technology Editors
MFG Tray names ChemTech International as its first Master Pharmaceutical Distributor.
Advertisement
Molded Fiber Glass Tray (MFG Tray) has selected ChemTech International as its master pharmaceutical distributor because of ChemTech’s market growth success and the longtime relationship with MFG Tray, according to a MFG Tray press release. The designation, the first offered by MFG Tray, means the ChemTech team is a trusted and valued partner and broadens ChemTech’s opportunities and responsibilities with MFG Tray.
The pharmaceutical line of products manufactured by MFG Tray are used worldwide in the pharmaceutical, nutraceutical, biotech, vaccine, lyophilization, and veterinary science markets. Since 1992, ChemTech has exported and distributed MFG Tray’s pharmaceutical products to destinations including the European Union, South Africa, Southeast Asia, India, South America, and Australia.
Source:
Advertisement
Related to this article
The FDA opened an expedited IND pilot, tightened scrutiny of foreign trial data, and finalized a rule recognizing non-animal testing methods. In Europe, the EMA advanced pharmaceutical legislation reform, restricted 2 legacy products, and opened an injectable-iron safety review.
Novartis licenses Abogen's mRNA-encoded T-cell engager for autoimmune disease, raising scale-up questions for mRNA-lipid nanoparticle manufacturing.
Pharma manufacturing spent 90 years learning that producing correct outputs isn't the same as catching your own errors. AI has only learned the first.
Ron Scarboro, Azurity Pharmaceuticals, explains why real-world usability belongs at product definition and how post-launch feedback should guide drug formulation.
Ronald Piervincenzi, USP, explains why drug supply resilience needs a system approach, from procurement benchmarks to regulatory capacity building.
Gene manufacturing platforms, patient-centric formulations, contract services, packaging innovations, and sterile filling lines are in the spotlight at CPHI Milan 2026.
Ronald Piervincenzi, USP, explains why drug supply resilience needs a system approach, from procurement benchmarks to regulatory capacity building.
Advertisement
Advertisement